...
首页> 外文期刊>European radiology >How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?
【24h】

How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?

机译:如何利用LI-RAD的LR-M特征,改善肝细胞癌组合肝胆胆管癌对乙二醇酸酯增强MRI的诊断?

获取原文
获取原文并翻译 | 示例
           

摘要

ObjectivesTo investigate the diagnostic accuracy of each LR-M feature defined in version 2017 of the Liver Imaging Reporting and Data System (LI-RADS) and determine the optimal LR-M feature for differentiating combined hepatocellular-cholangiocarcinoma (cHCC-CCA) and hepatocellular carcinoma (HCC) on gadoxetate-enhanced magnetic resonance imaging (MRI).MethodsNinety-nine patients with pathologically proven cHCC-CCA (n=33) or HCC (n=66) after surgery were identified. Two radiologists retrospectively assessed preoperative gadoxetate-enhanced MRI for features favoring non-HCC malignancies (LR-M features) according to LI-RADS version 2017. Multivariate logistic regression analysis was performed to determine the independent differential features. The sensitivity and specificity for diagnosing cHCC-CCA were calculated for each LR-M feature.ResultsTargetoid appearance showed the highest sensitivity (75.8%, 95% confidence interval [CI] 60.6%, 87.3%) to correctly identify cHCC-CCA as LR-M. At least one LR-M feature was observed in 31 (93.9%) patients with cHCC-CCA and 34 (51.5%) patients with HCC. The sensitivity and specificity for diagnosing cHCC-CCA using the presence of any one of the LR-M features were 93.9% (95% CI 80.7, 98.9) and 48.5% (95% CI 41.9, 51.0), respectively. The presence of three LR-M features yielded the highest diagnostic accuracy of 80.8% (95% CI 72.1, 86.1) with a reduced sensitivity of 54.5% (95% CI 41.4, 62.5).ConclusionThe majority of cHCC-CCA cases can be properly categorized as LR-M when any one of the LR-M features defined in the LI-RADS version 2017 is used as a determiner. However, approximately half of HCC cases also show at least one LR-M feature.Key Points center dot Targetoid appearance, including rim APHE, peripheral washout appearance, and delayed central enhancement, was the LR-M feature that identified cHCC-CCA as a non-HCC malignancy with the highest sensitivity.center dot Most cHCC-CCA cases can be properly categorized as LR-M when the presence of any one of the LR-M features was used as the determiner.center dot Approximately half of HCC cases also showed at least one LR-M feature.
机译:Objectivesto调查肝脏成像报告和数据系统(Li-RADS)的版本2017年中定义的每个LR-M特征的诊断准确性,并确定用于区分肝细胞癌和肝细胞癌和肝细胞癌的最佳LR-M特征(HCC)上鉴定丙酸酯增强的磁共振成像(MRI)。鉴定了手术后的病于病理证明CHCC-CCA(n = 33)或HCC(n = 66)的患者。两个放射科医生回顾性评估了术前的乙酰芳酸酯增强的MRI,用于根据LI-RADS版本2017的非HCC恶性肿瘤(LR-M功能)的特征。进行多变量逻辑回归分析以确定独立的差异特征。针对每个LR-M特征计算诊断CHCC-CCA的敏感性和特异性。结果表明最高敏感性(75.8%,95%置信区间[CI] 60.6%,87.3%),以正确识别CHCC-CCA作为LR- M.在31例(93.9%)的CHCC-CCA和34名(51.5%)的HCC患者中观察到至少一个LR-M功能。使用LR-M特征的存在诊断CHCC-CCA的敏感性和特异性分别为93.9%(95%CI 80.7,98.9)和48.5%(95%CI 41.9,51.0)。三种LR-M特性的存在产生了80.8%(95%CI 72.1,86.1)的最高诊断准确度,灵敏度降低了54.5%(95%CI 41.4,62.5)。结论大多数CHCC-CCA病例可以适当当LI-RADS版本2017中定义的任何一个LR-M功能用作确定器时,将作为LR-M分类。然而,大约一半的HCC案例也显示了至少一个LR-M功能.Key点中心点托管外观,包括轮辋Aphe,外围冲洗外观和延迟的中央增强,是将CHCC-CCA识别为a的LR-M功能具有最高灵敏度的非HCC恶性肿瘤。当使用任何一个LR-M功能的存在时,大多数CHCC-CCA案件可以被适当地分类为LR-M作为MEDER.CONER DOT大约一半的HCC壳体显示至少一个LR-M功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号